ACTIVE

NEOGEN

Financial year 2025 · Closed on 31/12/2025

Net result2,4 M €-20,8 %over 1 year

Gross margin2,1 M €-24,7 %over 1 year

Equity14,1 M €+20,5 %over 1 year

Identity

Source · BCE/KBO

NEOGEN is a Public limited company incorporated in 1991. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Anderlecht.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0445.922.856
Incorporation: 09/12/1991
Legal form: Public limited company
Registered office: Square Marie Curie 50
1070 Anderlecht · BruxellesSee on map
Contributed capital: 12 392 600,00 €
Latest accounts: 31/12/2025

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 24421Aluminium production

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	2,1 M €	-24.7%	2,8 M €	-0.7%	2,8 M €	+55.4%	1,8 M €	+12.1%	1,6 M €
EBITDA	2,1 M €	-23.9%	2,7 M €	-0.1%	2,8 M €	+53.0%	1,8 M €	+130%	780,7 k €
Operating result	1,7 M €	-26.5%	2,4 M €	+0.7%	2,4 M €	+217%	744,1 k €	+2324%	30,7 k €
Net result	2,4 M €	-20.8%	3 M €	+5.9%	2,9 M €	+203%	939,7 k €	+1136%	76,1 k €
Balance sheet
Equity	14,1 M €	+20.5%	11,7 M €	+34.8%	8,7 M €	+49.0%	5,8 M €	+19.3%	4,9 M €
Total assets	17,8 M €	+16.8%	15,2 M €	+16.0%	13,1 M €	+18.0%	11,1 M €	+0.8%	11 M €
Cash	31,4 k €	-35.4%	48,6 k €	-24.6%	64,5 k €	-37.9%	103,9 k €	+82.8%	56,8 k €
Debts	1,1 M €	+224%	331,3 k €	-59.9%	825,7 k €	-26.4%	1,1 M €	-20.6%	1,4 M €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 14 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LMDC Advisory s.r.o. BORepresented by Libor Matyasek	Managing director01/01/2026 → 11/06/2031
Cellular Consulting BORepresented by Bruno Febra	Director04/09/2025 → 11/06/2031
LMDC GmbH BORepresented by Libor Matyasek	Managing director01/07/2024 → 31/12/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LMDC GmbHRepresented by Libor Matyasek	Managing director01/07/2024 → 2024 accounts
Cellular ConsultingRepresented by Bruno Febra	Director01/01/2022 → 2024 accounts
Cellular Consulting LDARepresented by Bruno Febra	Director31/12/2021 → 2023 accounts
HANDS-ON FINANCE SOLUTIONS0825.704.085Represented by Ivo Peeters	Director12/02/2020 → 01/07/2024

Other companies at this address

Square Marie Curie 50 1070 Anderlecht

Company	CBE no.
A.forall Development● Active	0827.869.165
A.forall Group● Active	0684.777.042
Maatschap Eden● Active	0730.754.250
MEDIGROUP● Active	0826.773.857
S.A. ISTA N.V.● Active	0417.918.263

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/10/2026	25/09/2025	09/07/2024	29/08/2023	05/07/2022	09/09/2021
General meeting	23/10/2026	04/09/2025	28/06/2024	04/08/2023	30/06/2022	24/08/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/10/2026	27/10/2026	Dutch	PDF
Abridged model	31/12/2024	04/09/2025	25/09/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	09/07/2024	Dutch	PDF
Abridged model	31/12/2022	04/08/2023	29/08/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	05/07/2022	Dutch	PDF
Abridged model	31/12/2020	24/08/2021	09/09/2021	Dutch	PDF
Abridged model	31/12/2019	08/07/2020	14/07/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	09/07/2019	Dutch	PDF
Full model	31/03/2018	28/09/2018	26/10/2018	Dutch	PDF
Full model	31/03/2017	29/09/2017	08/11/2017	Dutch	PDF
Full model	31/03/2016	30/09/2016	26/10/2016	Dutch	PDF
Full model	31/03/2015	25/09/2015	15/02/2016	Dutch	PDF
Full model	31/03/2014	26/09/2014	28/10/2014	Dutch	PDF
Full model	31/03/2013	27/09/2013	12/02/2014	Dutch	PDF
Abridged model	31/03/2012	28/09/2012	23/11/2012	Dutch	PDF
Abridged model	31/03/2011	17/11/2011	28/11/2011	Dutch	PDF
Abridged model	31/03/2010	24/09/2010	27/09/2010	Dutch	PDF
Abridged model	31/03/2009	25/09/2009	28/09/2009	Dutch	PDF
Abridged model	31/03/2008	28/09/2008	28/11/2008	Dutch	PDF
Abridged model	31/03/2007	28/09/2007	01/10/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 14 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LMDC Advisory s.r.o. BORepresented by Libor Matyasek	Managing director01/01/2026 → 11/06/2031
Cellular Consulting BORepresented by Bruno Febra	Director04/09/2025 → 11/06/2031
LMDC GmbH BORepresented by Libor Matyasek	Managing director01/07/2024 → 31/12/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LMDC GmbHRepresented by Libor Matyasek	Managing director01/07/2024 → 2024 accounts
Cellular ConsultingRepresented by Bruno Febra	Director01/01/2022 → 2024 accounts
Cellular Consulting LDARepresented by Bruno Febra	Director31/12/2021 → 2023 accounts
HANDS-ON FINANCE SOLUTIONS0825.704.085Represented by Ivo Peeters	Director12/02/2020 → 01/07/2024

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates16/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/01/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/10/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/02/2021
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring23/07/2020
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring26/05/2020
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

LMDC Advisory s.r.o. BO

Cellular Consulting BO

LMDC GmbH BO

LMDC GmbH

Cellular Consulting

Cellular Consulting LDA

Jacobsen Management

HANDS-ON FINANCE SOLUTIONS

Vilas Pharmaceutical Services ApS

GRNR Invest

A.forall Development

Eric Dubois

Show the 5 other mandates

19911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

NEOGEN

Square Marie Curie 50, 1070 Anderlecht

Managing director

Director

Managing director

Director

DirectorManaging director

Director

Managing directorDirector

Director

DirectorManaging director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Square Marie Curie 50, 1070 AnderlechtCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00569845

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
NEOGENCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00569845

Events

2025
Annual accounts 20252,4 M €↓
2024
Annual accounts 20243 M €↑
2023
Annual accounts 20232,9 M €↑
2022
Annual accounts 2022939,7 k €↑
2021
Annual accounts 202176,1 k €↑
2019
Annual accounts 2019-571,8 k €↓
2018
Annual accounts 2018298,4 k €↑
2018
Annual accounts 2018-407,7 k €↑
2017
Annual accounts 2017-476 k €↑
2016
Annual accounts 2016-798,9 k €↑
2015
Annual accounts 2015-1,3 M €↓
2014
Annual accounts 2014645,9 k €↓
2013
Annual accounts 2013694,6 k €↑
2012
Annual accounts 2012-323,7 k €↑
2011
Annual accounts 2011-680,7 k €↓
2010
Annual accounts 2010-644,6 k €↓
2009
Annual accounts 2009-447,6 k €↓
2007
Annual accounts 200757,8 k €
09/12/1991
IncorporationPublic limited company

NEOGEN

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events